ABSTRACT Background and Aims Type 2 diabetes mellitus (T2DM) is an increasing worldwide health issue that carries considerable economic implications. Traditional management approaches often fail to provide continuous support between clinical visits, creating gaps in care that lead to suboptimal outcomes. Mobile health (mHealth) innovations have become effective solutions to address these challenges through real‐time monitoring and personalized guidance. Therefore, we reviewed the efficacy of mobile health technologies in improving the outcomes of patients with T2DM. Methods This narrative review was conducted by searching PubMed from January 2015 to January 2025, using Keywords such as Type 2 Diabetes Mellitus, Telemedicine, mHealth, and mobile applications. Results Out of 1356 studies, 36 studies met the criteria for final evaluation. Mobile health innovations hold significant promise for enhancing both clinical and patient‐reported outcomes. These technologies have been shown to positively impact clinical parameters such as glycemic control and cardiovascular risk factors, as well as patient‐reported outcomes such as self‐efficacy and quality of life. Conclusion Despite growing evidence supporting mHealth clinical utility among patients with T2DM, mobile health solutions still face implementation barriers, including data processing challenges and limited clinical integration.
Gohardehi et al. (Mon,) studied this question.